P063/O11 Inhibition of arginase-1 expression by the transcription factor Fra-1 in macrophages exacerbates rheumatoid arthritis inflammation. (March 2019)
- Record Type:
- Journal Article
- Title:
- P063/O11 Inhibition of arginase-1 expression by the transcription factor Fra-1 in macrophages exacerbates rheumatoid arthritis inflammation. (March 2019)
- Main Title:
- P063/O11 Inhibition of arginase-1 expression by the transcription factor Fra-1 in macrophages exacerbates rheumatoid arthritis inflammation
- Authors:
- Hannemann, N
Cao, S
Schnelzer, A
Jordan, J
Eberhardt, M
Schleicher, U
Uebe, S
Ekici, A
Rech, J
Bäuerle, T
Bogdan, C
Vera, J
Schett, G
Bozec, A - Abstract:
- Abstract : Career situation of first and presenting author: Student for a master or a PhD. Introduction: The activator protein (AP)-1 transcription factor family, especially its subfamily of FOS proteins (cFos, FosB, Fra-1 and Fra-2) are associated to the regulatory network of macrophage responses. Moreover, it is well known that macrophages are central player during rheumatoid arthritis (RA). Objectives: This study aims to delineate the role of Fra-1 in macrophages during the acute destructive inflammatory phase of RA. Methods: Therefore, we applied the serum-induced arthritis (K/BxN) model to Fra-1 deficient mice controlled by the Mx1 promoter (Fra-1 ΔMx ) or the LysM promoter (Fra-1 ΔLysM ). Moreover, we performed in vitro analyses of macrophage polarization in wildtype and Fra-1 deficient macrophages, as well as micro-arrays and ChIP sequencing analyses to delineate Fra-1 targets in activated macrophages. We completed our analysis by studying Fra-1 expression in RA patients' synovium. Results: Fra-1 mutant mice had decreased arthritis severity compared to their littermate wildtype mice. The alleviated arthritis was accompanied to increased arginase-1 (Arg1) expression and activity in the joints, suggesting that its anti-inflammatory features milder RA inflammation. Sorting of immune cell populations revealed macrophages as the major source of Arg1, which was increased in Fra-1 mutant mice. Mechanistically, Fra-1 transcriptionally inhibited Arg1 expression in macrophages.Abstract : Career situation of first and presenting author: Student for a master or a PhD. Introduction: The activator protein (AP)-1 transcription factor family, especially its subfamily of FOS proteins (cFos, FosB, Fra-1 and Fra-2) are associated to the regulatory network of macrophage responses. Moreover, it is well known that macrophages are central player during rheumatoid arthritis (RA). Objectives: This study aims to delineate the role of Fra-1 in macrophages during the acute destructive inflammatory phase of RA. Methods: Therefore, we applied the serum-induced arthritis (K/BxN) model to Fra-1 deficient mice controlled by the Mx1 promoter (Fra-1 ΔMx ) or the LysM promoter (Fra-1 ΔLysM ). Moreover, we performed in vitro analyses of macrophage polarization in wildtype and Fra-1 deficient macrophages, as well as micro-arrays and ChIP sequencing analyses to delineate Fra-1 targets in activated macrophages. We completed our analysis by studying Fra-1 expression in RA patients' synovium. Results: Fra-1 mutant mice had decreased arthritis severity compared to their littermate wildtype mice. The alleviated arthritis was accompanied to increased arginase-1 (Arg1) expression and activity in the joints, suggesting that its anti-inflammatory features milder RA inflammation. Sorting of immune cell populations revealed macrophages as the major source of Arg1, which was increased in Fra-1 mutant mice. Mechanistically, Fra-1 transcriptionally inhibited Arg1 expression in macrophages. Moreover, inhibition of Arginase in Fra-1 mutant mice restored a full blunt inflammatory RA response and the supplementation of mice with l-arginine, leading to increased arginase activity in the joint, is sufficient to milder arthritis. Synovium histological sections from RA patients showed a correlation between Arg1, Fra-1 and the DAS28 score, confirming that increased Arg1 activity is of benefit also for human inflammatory joint disease. Conclusions: Our data show for the first time that Fra-1 is a pivot between pro- and anti-inflammatory macrophage. By inhibiting Arg1 activity, Fra-1 exacerbates RA inflammation and joint destruction. Disclosure of Interest: None declared. … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 78(2019)Supplement 1
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 78(2019)Supplement 1
- Issue Display:
- Volume 78, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 78
- Issue:
- 1
- Issue Sort Value:
- 2019-0078-0001-0000
- Page Start:
- A27
- Page End:
- A27
- Publication Date:
- 2019-03
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2018-EWRR2019.53 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18240.xml